Exhibit 107
Calculation of Filing Fee Tables
FORM S-3
(Form Type)
MATINAS BIOPHARMA HOLDINGS, INC.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
Security Type | Security Class Title | Fee Calculation or Carry Forward Rule | Amount Registered (1) | Proposed Maximum Offering Price Per Unit (2) | Maximum Aggregate Offering Price(2) | Fee Rate | Amount of Registration Fee | ||||||||||||||||||||||||
Fees to Be Paid | Equity | Common Stock, par value $0.0001 | Other | 16,894,212 | $ | 0.561 | $ | 9,477,652.94 | 0.0001531 | $ | 1,451.03 | ||||||||||||||||||||
Total Offering Amounts | $ | 9,477,652.94 | $ | 1,451.03 | |||||||||||||||||||||||||||
Total Fees Previously Paid | $ | 0 | |||||||||||||||||||||||||||||
Total Fee Offsets | $ | 0 | |||||||||||||||||||||||||||||
Net Fee Due | $ | 1,451.03 |
(1) | Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), the shares of common stock issuable upon the conversion or exercise, of the Preferred Stock and Warrants, as applicable, offered hereby also include indeterminate number of additional shares of common stock as may be issued or issuable because of stock splits, stock dividends stock distributions, and similar transactions. |
(2) | Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) under the Securities Act. The proposed maximum offering price per share and maximum aggregate offering price are based upon on a per share price of $0.561, the average of the high and low prices of the Registrant’s Common Stock on the NYSE American LLC on April 15, 2025. |